Aflac Incorporated (NYSE:AFL) Stake Reduced by Iron Horse Wealth Management LLC

Iron Horse Wealth Management LLC decreased its position in Aflac Incorporated (NYSE:AFL) by 27.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,178 shares of the financial services provider’s stock after selling 842 shares during the period. Iron Horse Wealth Management LLC’s holdings in Aflac were worth $244,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Y.D. More Investments Ltd purchased a new position in Aflac in the 2nd quarter worth about $25,000. Dixon Mitchell Investment Counsel Inc. purchased a new position in shares of Aflac in the first quarter worth approximately $34,000. Fairscale Capital LLC acquired a new stake in Aflac during the 2nd quarter valued at $54,000. Cedar Wealth Management LLC acquired a new position in Aflac during the first quarter valued at $50,000. Finally, HHM Wealth Advisors LLC lifted its position in shares of Aflac by 178.6% in the second quarter. HHM Wealth Advisors LLC now owns 624 shares of the financial services provider’s stock worth $56,000 after purchasing an additional 400 shares in the last quarter. Institutional investors and hedge funds own 67.44% of the company’s stock.

Aflac Trading Down 0.1 %

Shares of NYSE:AFL traded down $0.07 during mid-day trading on Wednesday, reaching $112.09. The stock had a trading volume of 207,712 shares, compared to its average volume of 2,219,904. Aflac Incorporated has a twelve month low of $75.07 and a twelve month high of $115.50. The company has a current ratio of 0.10, a quick ratio of 0.10 and a debt-to-equity ratio of 0.29. The firm has a market cap of $63.69 billion, a PE ratio of 12.38, a price-to-earnings-growth ratio of 2.62 and a beta of 0.95. The firm has a 50 day simple moving average of $109.84 and a two-hundred day simple moving average of $96.37.

Aflac (NYSE:AFL) last released its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.60 by $0.23. Aflac had a net margin of 28.35% and a return on equity of 16.22%. The company had revenue of $5.14 billion during the quarter, compared to analysts’ expectations of $4.10 billion. During the same quarter in the prior year, the company earned $1.58 earnings per share. The business’s quarterly revenue was down .7% compared to the same quarter last year. On average, research analysts predict that Aflac Incorporated will post 6.76 EPS for the current fiscal year.

Aflac Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, September 2nd. Investors of record on Wednesday, August 21st were given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.78%. The ex-dividend date of this dividend was Wednesday, August 21st. Aflac’s dividend payout ratio is currently 22.08%.

Insider Transactions at Aflac

In other Aflac news, Director Thomas J. Kenny sold 2,000 shares of the company’s stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $98.94, for a total value of $197,880.00. Following the transaction, the director now directly owns 18,158 shares in the company, valued at $1,796,552.52. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.90% of the stock is owned by company insiders.

Analysts Set New Price Targets

AFL has been the topic of several research analyst reports. Morgan Stanley boosted their price target on shares of Aflac from $91.00 to $98.00 and gave the company an “equal weight” rating in a report on Monday, August 19th. Barclays assumed coverage on Aflac in a research note on Wednesday, September 4th. They issued an “underweight” rating and a $96.00 price objective on the stock. JPMorgan Chase & Co. upped their target price on Aflac from $85.00 to $90.00 and gave the stock a “neutral” rating in a research report on Thursday, October 3rd. UBS Group upped their price objective on shares of Aflac from $84.00 to $109.00 and gave the stock a “neutral” rating in a report on Wednesday, August 14th. Finally, Truist Financial lifted their target price on shares of Aflac from $82.00 to $100.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $97.53.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.